singlestrand
positivesens
rna
ssrna
virus
constitut
largest
group
viral
agent
even
encapsid
viral
structur
protein
positivesens
rna
genom
suffici
initi
translat
viral
replic
upon
introduct
permiss
cell
infecti
natur
ssrna
viral
genom
made
amen
revers
genet
manipul
year
howev
properti
contribut
factor
classifi
mani
ssrna
virus
select
agent
sa
feder
select
agent
program
moreov
mani
ssrna
virus
highprior
biosafeti
level
andor
pathogen
subset
list
potenti
bioterror
agent
us
depart
health
human
servic
addit
complic
fulllength
cdna
ssrna
virus
sa
use
creat
rna
rescuerecov
pathogen
thu
instanc
larg
cdna
doublestrand
dna
dsdna
clone
contain
least
twothird
genom
may
also
regul
sa
positivesens
rna
virus
span
multipl
viru
famili
infecti
natur
genom
rna
coupl
sabiosafetybiosecur
concern
inhibit
rapid
remov
contain
transport
handl
rna
sampl
known
contain
viral
genom
outbreak
set
pose
challeng
time
sampl
process
sequenc
analysi
could
significantli
hamper
respons
outbreak
situat
typic
product
gener
infecti
materi
must
proven
longer
contain
infecti
viral
particl
infecti
genom
rna
prior
transfer
space
confirm
loss
infect
loi
typic
occur
via
blind
infect
test
subset
materi
place
permiss
cell
line
least
three
subsequ
passag
reason
transfer
cdna
nucleic
acid
laboratori
laboratori
difficult
timeconsum
process
mani
laboratori
investig
work
procedur
approv
institut
biosafeti
committe
howev
procedur
vari
institut
institut
exampl
facil
work
mosquitotransmit
ssrna
virus
includ
west
nile
viru
wnv
chikungunya
viru
chikv
consid
sa
facil
contain
ssrna
virus
sever
acut
respiratori
syndrom
coronaviru
sarscov
venezuelan
equin
enceph
viru
veev
classifi
sa
facil
safeti
protocol
allow
transfer
genom
rna
cdna
directli
scientist
final
facil
work
sa
footandmouth
diseas
viru
fmdv
plum
island
anim
diseas
center
piadc
train
safeti
personnel
allow
transfer
cdna
sampl
highcontain
laboratori
laboratori
inactiv
carri
valid
protocol
scenario
robust
univers
standard
oper
procedur
sop
elimin
infecti
materi
rapidli
gener
nextgener
sequenc
ng
librari
critic
need
fmdv
illustr
major
sa
biosafeti
biosecur
issu
surround
highconsequ
rna
virus
among
foreign
anim
diseas
virus
fmdv
contagi
histor
set
standard
biosafeti
biosecur
polici
procedur
requir
biosafeti
level
carri
infecti
viru
work
fmdv
biosafeti
level
agricultur
current
facil
author
work
fmdv
unit
state
piadc
safeti
consider
review
refer
fact
viral
rna
rna
deriv
infect
sampl
infecti
transfect
electropor
suscept
cell
result
strict
regul
nucleic
acid
deriv
fmdvinfect
materi
current
approv
methodolog
remov
fmdv
nucleic
acid
laboratori
piadc
involv
harsh
alkalin
thermal
treatment
potenti
deleteri
effect
put
ng
librari
mcintosh
person
commun
addit
remov
materi
deriv
divers
ssrna
pathogen
contain
requir
timeconsum
procedur
eg
multipl
blind
infect
passag
rule
presenc
infecti
materi
tremend
limit
capac
conduct
genom
research
viral
sampl
particularli
applic
ng
techniqu
understand
viral
pathogenesi
viral
ecolog
vaccin
develop
reason
present
substanti
need
univers
sop
gener
cdna
rapidli
reproduc
inactiv
virus
easili
assess
institut
biosafeti
committe
ibc
speed
transfer
nucleic
acid
highcontain
laboratori
laboratori
enabl
rapid
introduct
varieti
ng
pipelin
present
robust
sop
gener
highqual
barcod
cdna
directli
genom
rna
across
multipl
viru
famili
famili
repres
includ
picornavirida
alphavirida
flavivirida
coronavirida
genom
size
kb
kb
strategi
build
upon
establish
sequenceindepend
singleprim
amplif
sispa
method
data
prove
barcod
ng
sequenc
librari
rapidli
gener
simultan
destroy
viral
particl
genom
rna
infect
approach
scalabl
highli
adapt
sensit
sop
gener
highqual
sequenc
span
entir
genom
pool
barcod
sampl
examin
singl
ng
run
product
sop
work
multipl
ng
platform
eg
illumina
miseq
hiseq
nextseq
ion
torrent
sop
work
start
materi
purifi
viru
tissu
cultur
sampl
tissu
sampl
abl
detect
virusspecif
read
sampl
input
fewer
pfu
identifi
virus
present
unknown
sampl
therefor
applic
potenti
rapid
sequenc
hightit
viral
stock
well
viru
discoveri
andor
forens
final
nonspecif
natur
amplif
make
sop
adapt
negativestrand
rna
virus
doublestrand
rna
dsrna
singlestrand
dna
ssdna
doublestrand
dna
dsdna
virus
overview
approach
illustr
nine
major
step
fig
first
viral
rna
isol
use
commerci
avail
rneasi
kit
trizol
second
purifi
viral
rna
use
templat
sequenceindepend
cdna
synthesi
random
librari
barcod
pcr
product
construct
third
dna
product
sop
treat
rnase
fourth
sop
product
purifi
point
test
product
sop
loss
viral
infect
absenc
infecti
fulllength
viral
genom
rna
step
highlight
yellow
fig
includ
final
sop
sinc
method
viru
specif
fifth
immedi
prior
transfer
sampl
heat
min
inactiv
potenti
viru
contamin
could
inadvert
occur
cdna
gener
purif
sixth
sampl
transfer
space
seventh
product
sop
pool
subject
ng
librari
construct
eighth
librari
sequenc
ninth
sequenc
data
analyz
comput
assembl
standard
offic
space
full
detail
protocol
sop
provid
supplement
method
text
supplement
materi
sequenceindepend
singleprim
amplif
sispa
util
random
hexam
primer
coupl
uniqu
barcod
fig
oligonucleotid
gener
singlestrand
cdna
input
rna
doublestrand
dna
randomli
prime
synthes
cdna
final
pcr
step
primer
encod
barcod
sequenc
amplifi
uniqu
barcod
sampl
result
small
pcr
product
gener
uniqu
barcod
terminu
randomli
prime
amplicon
repres
gel
imag
display
product
sop
obtain
serial
dilut
genom
human
rhinoviru
virion
rna
high
input
rna
amount
smear
bp
kb
visibl
signal
intens
diminish
start
materi
dilut
fig
upstream
step
may
requir
prior
initi
sop
start
hightit
viru
stock
directli
proceed
sop
fig
provid
investig
suffici
sampl
puriti
obtain
viral
sequenc
data
span
major
viral
genom
heterogen
sampl
eg
virusinfect
cell
host
rna
deplet
step
rrna
mrna
remov
may
requir
enrich
virusspecif
sequenc
proceed
sop
fig
sought
perform
sop
multipl
laboratori
test
divers
viru
famili
therefor
standard
version
sop
distribut
laboratori
expertis
work
variou
ssrna
viru
famili
proofofprincipl
experi
work
perform
ssrna
virus
repres
genom
coverag
fmdv
wnv
chikv
middl
east
respiratori
syndrom
coronaviru
merscov
obtain
illumina
miseq
sequenc
illustr
genom
coverag
achiev
viru
fig
e
area
low
coverag
observ
includ
termin
end
genom
larg
homopolym
region
poli
c
region
present
untransl
region
fmdv
date
sequenc
fmdv
sampl
merscov
sampl
wnv
sampl
hrv
sampl
chikv
sampl
repres
data
famili
summar
tabl
supplement
materi
advantag
system
abil
creat
singl
librari
hundr
barcod
sampl
rather
hundr
librari
dramat
reduc
time
cost
associ
reagent
labor
case
sequenc
suffici
depth
minor
variant
differ
provid
refer
sequenc
may
determin
use
bioinformat
pipelin
integr
clcbio
softwar
custom
softwar
repres
wnv
data
fig
tabl
subject
minor
variant
analysi
identifi
base
chang
refer
sequenc
genbank
access
chang
combin
three
engin
mutat
posit
eight
addit
chang
present
viru
stock
serv
control
sequenc
analys
next
sought
evalu
abil
sop
inactiv
infecti
genom
rna
grna
infecti
viru
hightit
sampl
coronavirus
flavivirus
alphavirus
picornavirus
process
aliquot
sampl
use
test
infecti
viru
infecti
viral
grna
see
materi
method
tabl
current
blind
passag
potenti
infecti
materi
permiss
cell
standard
assay
infect
neg
result
blind
passag
often
requir
remov
product
facil
method
detect
infecti
viru
littl
pfu
infecti
viral
grna
limit
genom
tabl
viral
infect
present
test
sampl
deriv
six
differ
ssrna
virus
tabl
moreov
genom
rna
infect
present
test
sampl
case
positivecontrol
sampl
confirm
cell
line
clearli
detect
viral
infect
grna
infect
result
suggest
sop
complet
inactiv
infecti
materi
addit
heat
inactiv
step
includ
reduc
risk
residu
infecti
materi
leav
contain
heat
treatment
min
complet
abolish
infecti
wnv
seven
fmdv
serotyp
see
tabl
supplement
materi
heat
inactiv
chikv
merscov
perform
data
indic
abil
sop
elimin
infect
envelop
nonenvelop
ssrna
virus
moreov
highqual
sequenc
recov
heat
inactiv
sispa
product
wnv
see
fig
supplement
materi
import
note
nonsa
virus
rna
may
remov
rna
lysi
buffer
prior
cdna
gener
approv
individu
institut
biosafeti
committe
ibc
initi
result
demonstr
sop
remov
grna
infect
start
materi
deriv
hightit
ssrna
viral
stock
next
initi
experi
defin
specif
step
sop
grna
infect
abolish
work
small
rna
viru
highli
infecti
introduc
permiss
cell
first
determin
limit
detect
rna
infect
occur
rang
pfu
hela
cell
tabl
next
grna
pfu
equival
per
sampl
subject
either
entir
sop
stop
intermedi
step
diagram
fig
briefli
replic
select
step
sop
transfect
hela
cell
first
purifi
rna
pfu
transfect
hela
cell
prior
initi
sop
posit
control
transfect
second
sop
stop
pcr
amplif
pcr
product
purifi
third
sop
use
gener
pcr
product
treat
rnase
cocktail
purifi
fourth
final
product
sop
heat
inactiv
encompass
entir
sop
control
efficaci
rnase
cocktail
rna
pfu
treat
amount
rnase
sop
materi
group
transfect
hela
cell
subject
three
blind
passag
demonstr
infect
destroy
result
clearli
indic
infecti
grna
remov
step
pcr
fig
like
result
temperatur
cycl
condit
howev
rule
contribut
rnase
h
cdna
synthesi
step
degrad
infecti
grna
describ
supplement
sop
text
supplement
materi
moreov
subsequ
rnase
step
final
heat
treatment
min
serv
addit
safeti
checkpoint
data
suggest
pcr
step
downstream
rnase
cocktail
inactiv
grna
least
pfu
equival
prove
abil
sop
inactiv
grna
extrem
robust
build
data
obtain
similar
approach
follow
fmdv
fig
corrobor
result
fmdv
grna
infect
abolish
postpcr
absenc
rnase
cocktail
fig
two
experi
highlight
sop
effici
inactiv
infecti
grna
earli
step
sop
subsequ
step
serv
addit
failsaf
inactiv
true
fmdv
support
data
tabl
clearli
demonstr
sop
abolish
grna
infect
across
divers
viru
famili
determin
sensit
sop
across
multipl
sequenc
platform
sequenc
ident
librari
gener
sop
miseq
hiseq
repres
data
serial
dilut
experi
show
limit
detect
lod
sequenc
read
approxim
pfu
fig
hiseq
platform
produc
averag
sequenc
read
sampl
howev
addit
read
improv
overal
genom
coverag
limit
detect
fig
therefor
conclud
miseq
platform
abl
sequenc
viral
read
present
librari
hiseq
platform
simpli
deriv
sequenc
start
materi
next
sought
defin
sop
limit
detect
miseq
platform
directli
compar
sensit
sequencespecif
quantit
realtim
revers
transcriptas
pcr
qrrtpcr
separ
experi
dilut
virion
grna
pure
cellfre
supernat
contain
virion
mix
cellular
rna
spike
sampl
perform
test
fig
virion
dilut
seri
preced
rna
extract
follow
sop
test
fig
virion
rna
extract
hightit
stock
follow
serial
dilut
aliquot
dilut
subject
sop
test
fig
virion
dilut
describ
test
mix
hela
cell
total
rna
extract
tube
rrna
remov
proceed
sop
test
fig
aliquot
dilut
viral
rna
describ
test
ad
total
hela
cell
rna
rrna
remov
materi
subject
sop
repres
miseq
data
black
line
test
display
fig
number
sequenc
read
per
sampl
prior
initi
sop
aliquot
dilut
rna
sampl
analyz
qrrtpcr
determin
input
viral
rna
copi
number
red
line
input
valu
provid
comparison
sequenc
read
output
approxim
qrrtpcr
miseq
lod
experi
follow
qrrtpcr
lod
pfu
miseq
lod
pfu
test
qrrtpcr
lod
pfu
miseq
lod
pfu
test
qrrtpcr
lod
pfu
miseq
lod
pfu
test
qrrtpcr
lod
pfu
miseq
lod
pfu
test
expect
qrrtpcr
sensit
miseq
sequenc
howev
sop
advantag
qrrtpcr
requir
priori
knowledg
sequenc
interest
benefit
provid
sequenc
inform
known
unknown
sampl
evalu
abil
sop
detect
wnv
context
cell
whole
tissu
limit
dilut
wnvinfect
cell
spike
uninfect
cell
fig
uninfect
tissu
fig
method
detect
wnvspecif
read
infect
cell
spike
uninfect
cell
fig
infect
cell
spike
uninfect
tissu
fig
anoth
experi
design
determin
abil
sop
detect
wnvspecif
sequenc
read
acut
persist
infect
mous
tissu
studi
sop
perform
gener
librari
footpad
site
inocul
brain
target
organ
wnv
day
tissu
support
viral
product
infecti
viru
present
least
month
inocul
sampl
pool
sequenc
eight
hiseq
lane
ensur
suffici
sequenc
depth
proper
analysi
yield
million
read
per
sampl
viral
load
peak
footpad
day
diminish
day
fig
peak
brain
titer
occur
day
postinocul
fig
furthermor
virusspecif
read
detect
brain
one
anim
day
postinfect
underscor
power
sop
detect
low
level
viru
natur
infect
test
abil
sop
recov
viral
sequenc
unknown
sampl
sourc
three
viral
stock
subject
sop
anonym
ship
j
craig
venter
institut
jcvi
sequenc
data
analysi
blind
manner
fig
raw
data
underw
de
novo
assembl
larg
contig
bp
use
identifi
best
fulllength
viral
genom
refer
nucleotid
blast
search
sequenc
read
map
onto
select
refer
genom
map
coverag
determin
fig
st
loui
enceph
viru
slev
western
equin
encephalomyel
viru
weev
chikungunya
viru
chikv
obtain
genom
coverag
clearli
demonstr
abil
sop
rapidli
identifi
ssrna
virus
sampl
without
prior
inform
addit
success
identifi
unknown
sampl
mix
four
differ
viral
rna
wnv
slev
weev
chikv
data
shown
core
object
biosafeti
program
contain
potenti
harm
biolog
infecti
agent
standard
lab
practic
bsl
defin
transfer
potenti
infecti
materi
highcontain
facil
challeng
sometim
sourc
contain
breach
likewis
outbreak
situat
need
handl
sampl
contain
potenti
infecti
viral
genom
genet
materi
fall
sa
regul
high
contain
may
significantli
hinder
public
health
respons
report
demonstr
develop
robust
sop
gener
highqual
cdna
ssrna
virus
use
highli
parallel
process
quickli
safe
remov
sampl
contain
subsequ
genom
sequenc
similar
procedur
laboratori
protocol
gener
ng
sequenc
librari
ssrna
virus
exist
exampl
recent
report
describ
method
fmdv
wholegenom
sequenc
proven
destroy
infecti
materi
addit
complet
genom
coverag
data
confirm
fulllength
rna
cdna
dsdna
process
use
recoverrescu
infecti
virus
demonstr
sop
complet
inactiv
virus
divers
viru
famili
classifi
sa
consid
highconsequ
pathogen
sop
remov
infecti
genom
rna
simultan
amplifi
barcod
cdna
use
rescuerecov
virus
tabl
fig
sop
also
gener
highqual
cdna
librari
result
ng
data
cover
almost
entir
ssrna
viral
genom
sampl
test
fig
sispa
method
unabl
fulli
defin
viral
genom
termini
sinc
method
util
random
hexam
prime
therefor
addit
protocol
rapid
amplif
cdna
end
race
requir
sequenc
inform
procedur
sequenc
independ
util
known
unknown
virus
newemerg
regardless
prior
genom
inform
sequenc
independ
also
enabl
simultan
identif
multipl
pathogen
sampl
eg
coinfect
even
modifi
manufactur
pathogen
describ
strategi
effici
scalabl
inexpens
requir
reagent
equip
commonli
use
laboratori
wherea
ng
sequenc
equip
expens
difficult
maintain
especi
within
highcontain
laboratori
sop
build
establish
sispa
method
creat
small
overlap
fragment
barcod
ie
uniqu
tag
addit
nucleotid
termini
barcod
system
mani
advantag
barcod
dna
use
recoverrescu
virus
safe
transfer
sequenc
center
onsit
ship
largescal
sequenc
center
ii
system
allow
pcr
amplif
genom
materi
thu
limit
amount
sampl
low
copi
number
yield
whole
genom
iii
scale
highthroughput
sequenc
hundr
sampl
simultan
dramat
reduc
cost
effort
requir
ng
librari
construct
collabor
sop
perform
time
multipl
laboratori
demonstr
fulllength
genom
sequenc
obtain
use
detect
small
amount
viral
nucleic
acid
approach
sensit
qrrtpcr
strategi
appli
divers
start
materi
cell
cultur
supernat
infectedcel
monolay
anim
tissu
much
repres
data
shown
deriv
illumina
miseq
sop
appli
multipl
platform
includ
illumina
hiseq
ion
torrent
person
genom
machin
pgm
pgm
provid
rapid
turnaround
time
allow
viral
sequenc
data
obtain
hour
compar
longer
time
requir
illumina
platform
interest
result
studi
observ
illumina
miseq
hiseq
platform
similar
limit
detect
ident
ng
librari
fig
like
miseq
platform
sequenc
virusspecif
molecul
librari
hiseq
platform
add
read
start
materi
import
note
hiseq
platform
still
relev
host
gene
express
analysi
sinc
addit
sequenc
depth
critic
provid
adequ
coverag
across
mammalian
mrna
also
abl
directli
compar
sensit
sop
sequencespecif
quantit
qrrtpcr
method
fig
qrrtpcr
sensit
requir
prior
knowledg
sequenc
interest
sispa
detect
sequenc
limit
amount
virion
rna
sampl
major
sequenc
data
host
deriv
demonstr
abil
detect
low
level
wnvspecif
sequenc
persist
infect
mous
tissu
late
day
postinfect
fig
futur
studi
optim
sop
improv
assay
sensit
reduc
sequenc
cost
sampl
limit
start
materi
howev
data
illustr
valu
protocol
viru
discoveri
andor
forens
analys
extens
effort
direct
toward
prove
sop
abolish
viral
genom
infect
across
viru
famili
experiment
design
suffici
state
high
confid
sop
abolish
infect
follow
input
infecti
dose
sampl
high
ii
limit
detect
infect
test
low
iii
sampl
size
suffici
high
import
note
assign
confid
interv
assay
must
failur
variabl
final
outcom
eg
cultur
posit
infect
loss
infect
test
process
sampl
sinc
initi
experi
success
rate
tabl
abil
demonstr
rna
infect
lost
pcr
step
fmdv
fig
strongli
suggest
final
rnase
step
serv
addit
safeguard
remov
infecti
rna
final
heat
step
min
ensur
residu
infect
due
lab
contamin
present
prior
transfer
see
tabl
fig
supplement
materi
howev
step
consid
failsaf
demonstr
infect
abolish
pcr
step
fig
appli
ng
sequenc
rna
virus
repres
unparallel
capac
gener
larg
amount
sequenc
data
use
identifi
consensu
sequenc
well
minor
sequenc
variant
quasispeci
present
viral
popul
limit
fmdv
popul
divers
studi
explor
intrasampl
variat
serial
passag
presenc
fmdv
quasispeci
within
infect
anim
therefor
describ
sop
especi
promis
fmdv
genom
analys
overcom
cost
time
limit
use
convent
ng
protocol
fmdv
studi
larg
data
set
previou
studi
combin
ng
sanger
data
sequenc
avail
public
databas
studi
microevolutionari
process
fmdv
popul
multipl
scale
protocol
gener
consensu
level
genom
sequenc
fmdv
positivesens
polyadenyl
rna
virus
report
exclus
test
illumina
miseq
platform
contrast
sop
provid
extra
versatil
cost
effici
adapt
multipl
sequenc
platform
allow
analysi
barcod
sampl
singl
run
therefor
scalabl
costeffici
sop
describ
make
promis
approach
examin
quasispeci
larg
data
set
provid
suffici
sequenc
depth
examin
minor
variant
hightit
stock
see
tabl
supplement
materi
consist
previou
observ
also
found
lowest
coverag
highli
structur
repetit
region
optim
sop
requir
investig
lowlevel
viral
popul
structur
difficult
genom
area
start
materi
rapidli
evolv
ng
technolog
improv
abil
discov
novel
viral
sequenc
across
divers
sampl
type
transcriptom
analyz
histor
microarray
recent
ng
repres
anoth
approach
identifi
known
novel
viral
sequenc
given
sampl
review
refer
altern
viru
discoveri
approach
util
degener
primer
specif
viru
famili
virusspecif
probe
random
primer
signal
amplif
subsequ
ng
librari
construct
sispa
approach
coupl
barcod
sequenc
random
hexam
singl
oligonucleotid
requir
prior
knowledg
sampl
composit
fig
moreov
data
demonstr
abil
obtain
read
grna
correspond
fewer
pfu
fig
importantli
final
product
sop
small
dsdna
fragment
flank
sequenc
barcod
therefor
safe
stabli
ship
sequenc
facil
absenc
cold
chain
summari
univers
sop
cdna
product
reproduc
inactiv
infect
virus
speed
transfer
nucleic
acid
highcontain
laboratori
laboratori
ng
rapidli
perform
sop
suitabl
pathogen
sequenc
independ
util
known
unknown
agent
simultan
identifi
multipl
agent
final
collect
data
suggest
procedur
implement
easili
valid
institut
biosafeti
committe
across
research
laboratori
prior
gener
sequenc
data
sop
establish
work
institut
institut
includ
j
craig
venter
institut
jcvi
univers
plum
island
anim
diseas
center
piadc
univers
maryland
school
medicin
univers
north
hill
detail
standard
protocol
describ
procedur
reagent
suppli
supplement
materi
briefli
total
rna
extract
viral
stock
virusinfect
cell
virusinfect
tissu
random
hexam
oligonucleotid
coupl
uniqu
barcod
denot
use
firststrand
cdna
life
technolog
secondstrand
dna
new
england
biolab
synthesi
firststrand
cdna
synthesi
step
also
includ
treatment
rnase
h
catalog
new
england
biolab
see
text
supplement
materi
second
primer
specif
barcod
lack
random
hexam
use
gener
pcr
fragment
rang
size
approxim
bp
life
technolog
exampl
primer
sequenc
correspond
pcr
primer
sequenc
order
overcom
problem
associ
low
divers
first
cycl
illumina
read
modifi
sispa
protocol
ad
either
n
n
end
sispa
pcr
primer
barcod
use
equimolar
combin
modifi
primer
pcr
amplif
step
protocol
list
pcr
primer
sequenc
describ
previous
sop
product
treat
rnase
cocktail
life
technolog
purifi
qiagen
subset
sampl
subject
heat
inactiv
min
sampl
requir
loss
viru
rna
infect
subject
test
consist
specif
institut
biosafeti
standard
final
product
sop
ship
jcvi
pool
sequenc
illumina
miseq
two
pair
end
pe
sequenc
read
illumina
hiseq
two
pe
illumina
nextseq
two
pe
ion
torrent
chip
kit
platform
combin
jcvidevelop
clcbiodevelop
command
line
tool
use
process
read
data
ng
run
duplic
read
remov
read
demultiplex
base
sampl
specif
barcod
sequenc
read
sequenc
trim
remov
barcod
random
hexam
qualiti
trim
remov
lowqual
base
sispa
barcod
design
minimum
edit
distanc
two
barcod
demultiplex
two
error
may
allow
search
barcod
sequenc
termini
read
barcod
demultiplex
use
bespok
softwar
avail
http
sourceforgenetprojectsdeconvolv
identifi
sispa
barcod
sequenc
bin
trim
barcod
random
hexam
softwar
packag
may
use
well
sampl
known
input
sequenc
read
map
prespecifi
refer
sequenc
sampl
unknown
input
sequenc
read
de
novo
assembl
result
contig
longer
nucleotid
nt
use
search
appropri
refer
sequenc
avail
genbank
use
ncbi
blastn
nt
databas
filter
virus
taxonomi
identifi
id
taxid
closest
refer
chosen
read
map
select
refer
analys
number
read
map
refer
percent
genom
coverag
map
number
unmap
read
determin
suffici
sequenc
depth
avail
singl
nucleotid
polymorph
snp
determin
use
jcvi
custom
softwar
pipelin
appli
statist
test
minim
falseposit
snp
call
could
caus
type
sequencespecif
error
sse
may
occur
illumina
read
previous
identifi
describ
minimum
minor
allel
frequenc
threshold
signific
level
establish
user
number
minor
allel
observ
major
allel
observ
direct
minimum
minor
allel
frequenc
threshold
use
calcul
p
valu
base
binomi
distribut
cumul
probabl
p
valu
calcul
two
sequenc
direct
less
bonferronicorrect
signific
level
snp
call
accept
analys
use
signific
level
bonferroni
correct
test
direct
minimum
minor
allel
frequenc
threshold
fmdv
transcrib
rna
fmdv
cruzeiro
infecti
clone
lfbk
cell
use
assess
presenc
absenc
viral
infect
lfbk
cell
use
assess
presenc
absenc
viral
infect
previous
describ
cell
propag
use
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
antibiot
incub
briefli
flask
seed
lfbk
cell
h
rins
inocul
sispa
product
ml
serumfre
medium
h
adsorpt
ml
medium
serum
ad
flask
flask
incub
h
rock
platform
sampl
infect
observ
amplifi
three
blind
passag
cell
babi
hamster
kidney
cell
strain
clone
atcc
use
electropor
cell
maintain
minim
essenti
medium
mem
contain
tryptos
phosphat
broth
calf
serum
antibiot
nonessenti
amino
acid
gibcobrlinvitrogen
sispa
product
fmdv
rna
electropor
previous
describ
electropor
product
subsequ
passag
lfbk
cell
describ
assess
viral
infect
total
three
blind
passag
determin
limit
recoveri
system
electropor
serial
dilut
quantifi
recombin
wildtyp
rna
electropor
product
passag
minimum
three
time
lfbk
cell
infect
visual
check
daili
total
rna
isol
supernat
cell
lysat
previous
electropor
viral
rna
cdna
sispa
use
either
qiagen
rneasi
kit
valencia
ca
viral
rna
isol
kit
ambion
kingfish
magnet
particl
processor
thermo
scientif
highthroughput
analysi
rna
treat
rnasefre
dnase
sigmaaldrich
superscript
iii
revers
transcriptas
rt
life
technolog
use
cdna
synthesi
follow
manufactur
instruct
cdna
dilut
run
duplic
follow
describ
previous
fmdv
use
pathid
quantit
pcr
qpcr
reagent
appli
biosystem
thermocycl
appli
biosystem
sampl
consid
posit
threshold
cycl
ct
valu
viru
stock
fmdv
prepar
pfuml
quadrupl
tube
heat
min
min
min
min
control
sampl
store
titrat
plaqu
assay
two
stock
wnv
use
studi
one
stock
wnv
biolog
isol
anoth
stock
flwnv
deriv
infecti
cdna
clone
wnv
previous
describ
flwnv
contain
three
silent
mutat
engin
infecti
clone
thu
differenti
wnv
titer
viru
stock
determin
african
green
monkey
kidney
cell
vero
atcc
rna
isol
sampl
qiagen
rneasi
kit
accord
manufactur
instruct
initi
sampl
volum
isol
rna
elut
rnasefre
water
anim
studi
result
tissu
sampl
harvest
approv
iacuc
univers
rna
isol
tissu
use
combin
trizol
reagent
life
technolog
qiagen
rneasi
kit
tissu
section
mm
mm
mm
brain
spleen
liver
mice
place
ml
trizol
diamet
steel
ball
homogen
qiagen
mixer
mill
min
cycless
process
repeat
need
complet
homogen
observ
sampl
incub
min
room
temperatur
rt
prior
addit
chloroform
sampl
mix
incub
min
rt
centrifug
g
min
aqueou
fraction
transfer
fresh
tube
mix
cold
ethanol
ad
rneasi
column
rna
extract
follow
manufactur
instruct
rrna
deplet
total
rna
use
ribozero
magnet
kit
epicentr
madison
wi
accord
manufactur
instruct
rna
isol
describ
sispa
librari
gener
accord
univers
standard
oper
procedur
one
three
sispa
librari
pool
pool
ad
ml
viru
diluent
mem
plu
fb
negativecontrol
sampl
diluent
alon
positivecontrol
sampl
contain
pfu
prepar
parallel
sampl
inocul
flask
vero
cell
incub
h
rock
everi
min
five
millilit
complet
medium
mem
plu
fb
ad
flask
cell
incub
day
monolay
monitor
daili
cytopath
effect
cpe
cpe
appar
aliquot
collect
frozen
sampl
longer
passag
cpe
present
day
postinocul
dpi
ml
supernat
flask
inocul
onto
fresh
vero
cell
initi
infect
process
total
three
passag
determin
limit
detect
infecti
viru
dilut
wnv
pfu
inocul
onto
vero
cell
subject
four
round
blind
passag
describ
experi
run
triplic
cpe
evid
cell
infect
least
pfu
second
passag
mild
cpe
develop
one
flask
infect
pfu
fourth
passag
cpe
observ
cell
infect
less
pfu
presenc
infecti
wnv
rna
sispa
librari
assay
electropor
cell
follow
serial
passag
vero
cell
cell
trypsin
wash
resuspend
pb
concentr
cellsml
prepar
electropor
cell
ml
mix
water
sispa
pool
water
plu
wnv
rna
isol
viru
stock
describ
electropor
cuvett
cell
mixtur
puls
electropor
biorad
richmond
ca
three
time
v
rest
cell
incub
min
rt
transfer
flask
contain
ml
warm
complet
medium
cell
grown
observ
daili
cpe
day
ml
supernat
flask
inocul
onto
vero
cell
sampl
serial
passag
describ
determin
limit
rescu
infecti
rna
system
cell
mix
dilut
wnv
rna
genom
equival
ge
wnv
electropor
triplic
ge
calcul
isol
viral
rna
use
realtim
rtpcr
cell
supernat
inocul
onto
vero
cell
subject
four
blind
passag
cpe
rapidli
develop
cell
transfect
ge
cpe
develop
cell
transfect
less
ge
sispa
librari
consid
free
infecti
viru
rna
cpe
observ
end
third
passag
vero
cell
secondari
test
infecti
materi
supernat
final
passag
sampl
inocul
onto
vero
cell
duplic
infect
allow
continu
day
time
monolay
fix
examin
viru
antigen
immunofluoresc
monolay
stain
mous
hyperimmun
ascit
fluid
cdc
follow
fluorescein
isothiocyan
fitc
conjug
goat
antimous
kpl
visual
nikon
eclips
fluoresc
microscop
viral
antigen
observ
well
inocul
positivecontrol
wnv
sampl
absent
well
inocul
negativecontrol
sispa
librari
supernat
molecular
clone
obtain
atcc
rescu
viral
stock
plasmid
obtain
atcc
gener
viral
stock
genbank
access
supernat
contain
infecti
viru
isol
aliquot
genbank
refer
sequenc
use
design
quantit
revers
transcriptas
pcr
qrtpcr
taqman
primerprob
set
taqman
forward
primer
taqman
revers
primer
taqman
probe
fam
cagatccgcaaacaat
isol
rna
supernat
passag
frozen
subsequ
subject
rna
extract
use
qiagen
rneasi
kit
rna
treat
rnasefre
dnase
revers
transcript
perform
superscript
iii
revers
transcriptas
invitrogen
neg
control
monitor
contamin
water
use
place
superscript
iii
revers
transcriptas
case
revers
transcript
perform
oligo
dt
prime
cdna
dilut
run
duplic
use
taqman
custom
custom
primer
probe
appli
biosystem
platform
hela
cell
use
assess
presenc
absenc
viral
infect
visual
cpe
cell
propag
sixwel
plate
use
dmem
supplement
fetal
bovin
serum
incub
h
rna
transfect
perform
use
rna
cdna
sispa
product
follow
transitmrna
transfect
kit
protocol
miru
transfect
cell
incub
h
cpe
observ
daili
sampl
determin
cpe
neg
use
passag
specif
supernat
passag
use
infect
fresh
cell
h
h
ml
dmem
fb
ad
well
cell
incub
h
cpe
observ
daili
sampl
deem
cpe
neg
use
passag
follow
protocol
use
passag
experi
genom
rna
transfect
parallel
posit
control
rna
infect
largescal
loss
rna
infect
studi
sop
perform
sampl
sampl
format
briefli
well
use
make
eight
tube
pool
materi
etc
hela
cell
propag
petri
dish
use
dmem
supplement
fetal
bovin
serum
next
sispa
product
transfect
petri
dish
use
transitmrna
transfect
kit
miru
cell
incub
least
h
monitor
daili
appear
cpe
cpe
observ
ml
supernat
petri
dish
inocul
fresh
hela
cell
repeat
total
three
passag
experi
genom
rna
transfect
parallel
posit
control
rna
infect
determin
limit
detect
infecti
rna
rna
isol
dilut
virion
particl
rna
transfect
onto
hela
cell
use
transitmrna
transfect
kit
miru
subject
three
round
blind
passag
cpe
evid
cell
infect
least
pfu
second
passag
cpe
observ
cell
infect
less
pfu
data
shown
limit
infect
infecti
rna
reproduc
multipl
replic
studi
largescal
loss
viral
infect
sop
perform
sampl
sampl
format
final
elut
volum
divid
four
aliquot
reduc
amount
cpe
test
sampl
row
pool
prior
cpe
test
briefli
well
use
make
eight
tube
pool
materi
etc
target
hela
cell
propag
flask
use
dmem
supplement
fetal
bovin
serum
incub
infect
studi
supernat
remov
pool
mix
ml
infect
medium
dmem
plu
fb
mix
use
infect
flask
h
gentli
rock
flask
everi
min
h
medium
replac
flask
incub
h
cpe
observ
ml
supernat
flask
inocul
fresh
hela
cell
repeat
total
three
passag
experi
infecti
viral
particl
serv
posit
control
cpe
determin
limit
detect
infecti
viru
dilut
inocul
onto
hela
cell
subject
three
round
blind
passag
describ
cpe
evid
cell
infect
least
pfu
second
passag
cpe
observ
cell
infect
less
pfu
data
shown
limit
infect
infecti
viru
reproduc
multipl
replic
alphaviru
sispa
test
done
use
either
infectiousclonederiv
girdwoodsa
strain
sindbi
viru
sinv
infectiousclonederiv
vaccin
strain
chikv
gener
provid
terri
dermodi
vanderbilt
univers
infecti
clone
engin
express
mkate
fluoresc
protein
follow
fmdv
proteas
frame
viral
capsid
gene
previous
describ
viru
stock
gener
product
viru
length
genom
rna
use
mmessag
mmachin
rna
transcript
kit
ambion
electropor
cell
describ
previous
titer
viral
stock
determin
use
standard
plaqu
assay
protocol
vero
cell
sispa
reaction
test
presenc
infecti
sinv
chikv
vero
cell
briefli
pool
sispa
librari
mix
ml
complet
mem
mem
plu
fb
lglutamin
lglut
penicillinstreptomycin
penstrep
vero
cell
place
flask
h
rock
everi
min
end
incub
ml
complet
medium
ad
flask
mock
control
flask
receiv
complet
medium
alon
firstpassag
monolay
maintain
h
monolay
assess
cytopath
effect
red
fluoresc
daili
h
supernat
passag
flask
introduc
onto
new
monolay
use
infect
protocol
flask
maintain
h
monolay
assess
cpe
red
fluoresc
everi
h
next
supernat
place
third
monolay
monitor
addit
h
assess
assay
sensit
cpe
protocol
also
perform
use
ml
complet
medium
contain
pfu
sinv
chikv
assay
sensit
routin
rang
pfu
test
alphaviru
rna
inactiv
sispa
reaction
bhk
cell
electropor
pool
sispa
sinv
chikv
librari
seed
flask
ml
mem
supplement
fb
lglut
penstrep
monolay
maintain
h
assess
cpe
red
fluoresc
everi
h
h
ml
supernat
transfer
new
flask
vero
cell
monitor
cpe
everi
day
h
point
supernat
place
third
monolay
vero
cell
assess
cpe
h
jordan
merscov
strain
genbank
access
kindli
provid
kanta
subbarao
nation
institut
health
bethesda
md
gabriel
defang
naval
medic
research
unit
cairo
egypt
michael
cooper
arm
forc
health
surveil
center
afhsc
emad
mohereb
experi
live
merscov
jordan
perform
biosafeti
level
condit
univers
maryland
school
medicin
vero
monkey
kidney
epitheli
cell
atcc
plaqu
assay
grown
minim
essenti
medium
corn
supplement
volvol
fb
sigma
aldrich
lglutamin
gibco
penicillinstreptomycin
gemini
bioproduct
atmospher
determin
titer
live
merscov
media
infect
cell
process
rna
place
vero
cell
determin
titer
pfu
per
millilit
previous
describ
quantifi
infect
sampl
throughout
describ
rna
isol
protocol
rna
cdna
intermedi
final
purifi
product
use
infect
vero
cell
sixwel
plate
cell
per
well
cell
passag
everi
h
blind
passag
well
cpe
examin
